These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3901210)

  • 21. Efficacy of imipenem/cilastatin in patients with severe bacterial infections.
    Reutter FW
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():141-4. PubMed ID: 3469186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical studies on imipenem/cilastatin sodium in pediatric field].
    Nagata K; Yokoyama M; Ohnishi A; Izumi Y
    Jpn J Antibiot; 1986 Jul; 39(7):1708-14. PubMed ID: 3464774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imipenem/cilastatin for pediatric infections in hospitalized patients.
    Nalin DR; Hart CB; Shih WJ; Aziz MA
    Scand J Infect Dis Suppl; 1987; 52():56-64. PubMed ID: 3331043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trial of imipenem/cilastatin versus gentamicin and clindamycin in mixed flora infections.
    Solomkin JS; Fant WK; Rivera JO; Alexander JW
    Am J Med; 1985 Jun; 78(6A):85-91. PubMed ID: 3890538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of skin and soft tissue infections with imipenem/cilastatin.
    Fass RJ; Freimer EH; McCloskey RV
    Am J Med; 1985 Jun; 78(6A):110-2. PubMed ID: 3890532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pneumonia treated with imipenem/cilastatin.
    Salata RA; Gebhart RL; Palmer DL; Wade BH; Scheld WM; Groschel DH; Wenzel RP; Mandell GL; Duma RJ
    Am J Med; 1985 Jun; 78(6A):104-9. PubMed ID: 3859208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect and tolerance of daily 2 X 1 g imipenem/cilastatin in general surgery].
    Wenzel M; Loch H
    Infection; 1986; 14 Suppl 2():S148-53. PubMed ID: 3531026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imipenem/cilastatin in the treatment of osteomyelitis.
    MacGregor RR; Gentry LO
    Am J Med; 1985 Jun; 78(6A):100-3. PubMed ID: 3859207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of imipenem/cilastatin in the treatment of soft tissue infections.
    Marier RL
    Am J Med; 1985 Jun; 78(6A):140-4. PubMed ID: 3890534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Imipenem/cilastatin sodium in the treatment of obstetric and gynecologic infections].
    Doko F
    Jpn J Antibiot; 1986 May; 39(5):1427-31. PubMed ID: 3463788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical evaluation of imipenem/cilastatin sodium in children].
    Meguro H; Arimasu O; Kobayashi M; Shiraishi H; Fujii R; Izumi K
    Jpn J Antibiot; 1986 Jul; 39(7):1715-32. PubMed ID: 3464775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of moderate or severe infections using imipenem/cilastatin. 41 cases based on a multicenter protocol].
    Stahl JP; Chavanet P; Robert D; Croize J; Mercatello A; Bru JP; Aguilaniu F; Portier H; Micoud M
    Pathol Biol (Paris); 1986 May; 34(5):465-9. PubMed ID: 3534723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical efficacy, safety and tolerability of intramuscular imipenem/cilastatin in the treatment of mild to moderate infections.
    Garau J; Casagrán A; Sánchez C; Matas E
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():181-3. PubMed ID: 3469192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fundamental and clinical evaluation of imipenem/cilastatin sodium in the field of pediatrics].
    Haruta T; Okura KE; Kuroki S; Yamamoto H; Yamaoka K; Kubo K; Kobayashi Y
    Jpn J Antibiot; 1986 Jul; 39(7):1879-88. PubMed ID: 2945941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized comparison of imipenem/cilastatin and ceftazidime in the empiric therapy of severe abdominal infections. A multicenter study.
    Broze B; De Mees J; Droissart R; Nolens VP; Staudt JP; Verstraeten ME; de Lame PA
    Acta Clin Belg; 1987; 42(6):431-6. PubMed ID: 3324599
    [No Abstract]   [Full Text] [Related]  

  • 36. Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin.
    Calandra GB; Brown KR; Grad LC; Ahonkhai VI; Wang C; Aziz MA
    Am J Med; 1985 Jun; 78(6A):73-8. PubMed ID: 3859218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imipenem/cilastatin efficacy evaluated.
    Bailie GR; Crossley KB; Rotschafer JC
    Drug Intell Clin Pharm; 1985 Nov; 19(11):840-1. PubMed ID: 3864632
    [No Abstract]   [Full Text] [Related]  

  • 38. The efficacy results and safety profile of imipenem/cilastatin from the clinical research trials.
    Calandra GB; Ricci FM; Wang C; Brown KR
    J Clin Pharmacol; 1988 Feb; 28(2):120-7. PubMed ID: 3283176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacokinetic and clinical studies with imipenem/cilastatin sodium in the pediatric field. Pediatric Study Group for Imipenem/Cilastatin Sodium].
    Fujii R; Meguro H; Arimasu O; Yoshioka H; Fujita K; Maruyama S; Inyaku F; Nagamatsu I; Wagatsuma Y; Takase A
    Jpn J Antibiot; 1986 Jul; 39(7):1912-37. PubMed ID: 3464785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of imipenem/cilastatin in treatment of complicated urinary tract infections.
    Cox CE; Corrado ML
    Am J Med; 1985 Jun; 78(6A):92-4. PubMed ID: 3859220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.